🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalUK Boots vs LloydsPharmacy — 12 month update Page 4

UK Boots vs LloydsPharmacy — 12 month update

LipidDoc_ATL Mon, Dec 15, 2025 at 8:53 PM 39 replies 1,780 viewsPage 4 of 8
sean_dublin
Member
212
890
Nov 2024
Dublin, IE
Dec 27, 2025 at 2:33 AM#16

Clinical perspective, offered as context rather than as advice. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

Last edited: Dec 27, 2025 at 3:33 AM
45 18hannah_MT, Dr.SportsMedIN, amy_econ_NJ and 42 others
Reply Quote Save Share Report
SallyK_inj
Member
567
2,345
Jul 2024
Iowa
Dec 28, 2025 at 6:46 PM#17
sean_dublin said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

I read this differently from sean_dublin, on substance rather than tone. This treats a plausible mechanism as a demonstrated one. Plausible is where you start looking, not where you stop.

46 19bbq_ray_KC, oliver_london, tane_welly and 43 others
Reply Quote Save Share Report
MarkLI_maint
Member
534
2,345
Jun 2024
Long Island, NY
Dec 30, 2025 at 11:01 AM#18
sean_dublin said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.

Last edited: Dec 30, 2025 at 4:01 PM
47 20HPLC_Greg, LibrarianMeg, bri_stats and 44 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.NephBHM_UK
Member
456
2,123
Jun 2024
Birmingham, UK
Jan 1, 2026 at 3:16 AM#19
sean_dublin said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

Thank you for spelling out the reasoning rather than just the conclusion. Sending this to two other people who asked me the same thing last week.

48 21SurmountFan_IN, PeptideChemSF, A1cHero_PHX and 45 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jan 2, 2026 at 7:33 PM#20

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful.

20 18PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 17 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register